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ABSTRACT  
  
Anthropometric measures relating to body size, weight and composition are  
increasingly being associated with cancer risk and progression.  Whilst practical in  
epidemiologic research, where population-level associations with disease are  
revealed, it is important to be aware that such measures are imperfect markers of the  
internal physiological processes that are the actual correlates of cancer development.   
Body mass index (BMI), the most commonly used marker for adiposity, may mask  
differences between lean and adipose tissue, or fat distribution, which varies across  
individuals, ethnicities, and stage in the lifespan.  Other measures, such as weight  
gain in adulthood, waist circumference and waist-to-hip ratio, contribute information  
on adipose tissue distribution and insulin sensitivity.  Single anthropometric  
measures do not capture maturational events, including the presence of critical  
windows of susceptibility (i.e. age of menarche and menopause), which presents a  
challenge in epidemiologic work.  Integration of experimental research on underlying  
dynamic genetic, hormonal and other non-nutritional mechanisms is necessary for a  
confident conclusion of the overall evidence in cancer development and progression.   
This article discusses the challenges confronted in evaluating and interpreting the  
current evidence linking anthropometric factors and cancer risk as a basis for issuing  
recommendations for cancer prevention.   
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INTRODUCTION  
Since the early 1980s, evidence has accumulated from a rapidly growing body of  
epidemiologic studies (1, 2) showing an association between increased adiposity and  
the risk and progression of cancer.  This association is supported by clinical studies  
(3, 4), which together with a better understanding of the biology of cancer (5) have  
helped to identify mechanisms through which energy balance might influence the  
cancer process. Together, this evidence supports a causal association between  
increased adiposity and cancer occurrence (1, 2, 6).   
  
Anthropometric measures reflecting body size and composition have been  
associated with site-specific cancer development (1), with growing evidence that  
body composition plays important role in cancer treatment, side effects and survival  
(7). These measures include height, weight and waist and hip circumference, and  
derived indices such as BMI, waist-to-hip ratio and waist-to-height ratio. Measures of  
birth size and weight, growth during childhood (sometimes linked with measures of  
maturation such as age at menarche or menopause), and/or change in weight in  
adulthood have also been considered if available.  However, the precise relationships  
between these variables are often poorly characterised (8).  Furthermore, these  
measures are subject to additional limitations in that they mask the processes  
underlying observed associations, such as developmental factors that may give rise  
to critical periods of susceptibility where intervention would be most beneficial.   
Measures that do not distinguish lean from adipose tissue may also obscure any  
separate roles of low lean mass and high adiposity in determining cancer risk.   
Consequently, it is important to be aware of the advantages and limitations of using  
anthropometry to unravel precise causal connections between nutritional state and  
cancer, particularly when using these to make clinical and public health  
recommendations.   
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In this paper, we draw on the experience from the World Cancer Research 
Fund/American Institute for Cancer Research (WCRF/AICR) Second Expert Report 
Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective 
(1) and the Continuous Update Project (2), in which systematic reviews and meta-
analyses are conducted on the links between nutritional exposures, anthropometric 
measures, and cancer risk.  An independent expert panel then judges the strength of 
the evidence based on the likely causality of associations using a priori criteria (see 
supplementary information), as a basis for making recommendations for cancer 
prevention.  The purpose of this article is to discuss key methodological challenges 
and issues in assessing and interpreting the evidence on anthropometric measures 
and cancer risk.  
 
ANTHROPOMETRIC FACTORS AND CANCER: ASSESSING THE EVIDENCE 
The role of epidemiologic studies  
The Continuous Update Project (2) has identified strong evidence for links between 
adiposity, adult weight gain, height, and several cancer types (see Table 1), based 
on a comprehensive review of the current epidemiologic literature and a-priori 
causality criteria (1) (see supplementary information).  Epidemiologic investigations 
are critical in understanding how anthropometric and other factors relate to site-
specific cancer risk and prognosis.  They represent the best available method for 
establishing population-wide associations in free-living individuals.  Assessing the 
overall body of evidence, however, requires the evaluation of studies that provide 
mechanistic insights, including in vitro investigations, animal studies, and human 
experimental studies on intermediate factors (for example, hormonal, metabolic, 
immunological, and epigenetic responses).  These mechanistic studies are important 
for ascribing causality to observed associations, and laboratory studies permit 
hypothesis-testing under controlled conditions to a greater degree than is feasible in 
free-living human populations. However, caution must be exercised as findings from 
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animal models and cell lines may not be directly generalisable to humans; in  
particular, the identification of susceptible individuals can only be determined in  
humans.  As randomised interventions on body size and composition and cancer risk  
are difficult, the current inference of causal relationships depends on a synthesis of  
evidence from human epidemiologic, metabolic, animal, and mechanistic studies.  
  
[Table 1 about here]  
  
Key challenges in evaluating the impact of adiposity on cancer risk  
Studies related to adiposity represent a unique challenge in epidemiology. Most  
epidemiologic studies have used anthropometric measures such as BMI, weight  
change over a specified time, and body circumference measures as markers of body  
composition. Although such markers are imperfect, and may reflect genetic and other  
non-nutritional factors, at a population level markers of adiposity (e.g., higher BMI or  
waist circumference) are strongly correlated with systemic and tissue factors that  
may potentially influence cancer, such as systemic low-grade inflammation,  
oestrogen levels in postmenopausal women, insulin resistance and hyperinsulinemia  
(9).   
  
Adipose tissue in humans is a structural and thermal buffer, a store of energy in the  
form of lipid (principally triglycerides), and an active endocrine organ involved in  
hormonal secretion and metabolism that contributes to appetite regulation, immune  
function and inflammation (10, 11). Abdominal visceral adipocytes are more  
metabolically active than abdominal subcutaneous adipocytes, as they have high  
lipolytic activity and release large amounts of free fatty acids (12, 13).  Some studies  
have shown that for certain cancers, abdominal obesity may be associated with risk  
for cancer independent of overall obesity (e.g. (14)).  Therefore, ideal measurements  
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of adiposity include the regional distribution and site of deposition of the adipose  
tissue, including that within and around specific organs.  
  
Evidence based on associations between anthropometric measures such as BMI and  
cancer is taken to represent adiposity, reflecting its interpretation in the biological  
context of a wider body of evidence.  High BMI itself is not a cause of cancer. It is  
interpreted as a marker, which, supported by a body of mechanistic evidence that  
biological factors related to adiposity can influence the risk of development or  
progression of cancer, is judged to be the causal exposure. Equally, it is uncertain  
whether waist circumference, or waist-to-hip ratio, should be interpreted as markers  
of visceral adipose tissue specifically, or of abdominal subcutaneous adipose tissue,  
or simply of total body fat.  As with BMI, the circumference itself is obviously not the  
causal factor, but uncertainty exists in its interpretation as a marker of the internal  
metabolic milieu that underpins the association.  
  
Similarly, adult attained height consistently predicts increased risk of several cancers  
(15), although clearly height is not the causal factor per se. Height acts as a marker  
for the complex interplay of genetic, nutritional and other environmental factors that  
determine the growth trajectory and culminate in final height. It must also be noted  
that adult height does not fully characterize the growth trajectory (either in terms of  
height or body composition). For instance, the timing of the BMI rebound in childhood  
(referred to as the ‘adiposity rebound’ (16)) during growth has been linked to  
susceptibility for other chronic conditions including subsequent obesity, metabolic  
syndrome, diabetes and cardiovascular disease (17, 18). It is uncertain whether there  
is also a link between adiposity during growth and cancer.  This may be an important  
avenue for exploration, given that known associations between birth weight and adult  
height operate in different directions for cardiovascular disease and cancer (19, 20).  
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In addition to issues of interpretation of anthropometric measurements as indicators  
of body composition in relation to cancer risk, observational evidence also needs to  
take account of potential confounders or effect modifiers such as smoking, alcohol  
intake and hormone use, as well as intermediate factors such as physical activity and  
specific dietary factors.  
  
Limitations of current anthropometric measurements  
Body Mass Index (BMI), defined as the quotient between weight in kilograms and  
height in meters squared (kg/m2), is the most commonly used marker of adiposity in  
epidemiologic studies due to simplicity of assessment, low costs and high precision  
and accuracy. Definitions for classifying and reporting population-level healthy  
weight, overweight and obesity have historically been based on anthropometric  
measures. Overweight and obesity are conventionally defined in relation to BMI in  
excess of 25 and 30 kg/m2, respectively (21) in most populations, with lower  
cutpoints for Asians (22, 23).   
  
Although BMI represents a useful indicator of adiposity, it is an imperfect measure of  
body composition, because it does not differentiate between lean and adipose tissue  
mass; the relative proportions of which vary between individuals, and with age, sex,  
and race/ethnicity (24, 25). In addition, BMI provides no information on the  
distribution of adipose tissue, whether central (in the abdomen, including the  
abdominal wall and viscera), peripheral (in the buttocks and extremities), or in the  
organ at risk. BMI is also less reliable as an indicator of adiposity among older  
people, due to reduction in height, loss of muscle (lean tissue) and increase in  
adipose tissue that occurs with aging, particularly after menopause in women (26).  
Thus, BMI shows a stronger (positive) correlation with estimates of adipose tissue in  
younger individuals, but shows a stronger (inverse) correlation with muscle tissue in  
older individuals (27).  
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Epidemiologic studies often rely on self-reported height and weight which may  
include systematic errors in calculations of BMI; people tend to under-report weight  
and over-report height (28). However, studies have shown a strong correlation (>0.9)  
between self-reported and measured weight and height (29-32).  Furthermore, the  
impact of such systematic measurement error on relative risk estimates in  
epidemiologic studies is generally small (33).  BMI cut-offs are therefore useful at the  
population level, but may not accurately reflect adiposity of individuals.    
  
Furthermore, comparison across studies examining cancer risk according to BMI is  
problematic if studies have assessed risk across specified quantiles. As the  
distribution of BMI varies between populations, at different stages of life and different  
time periods, the specific groupings may not be comparable. Other studies report risk  
according to WHO BMI categories, which may mask associations within these  
categories.   
  
Measures of adipose distribution typically include waist and hip circumferences,  
waist-to-hip ratio and waist-to-height ratio.  Waist and hip circumference  
measurements show greater inter-observer variability than assessments of weight or  
height.  This is in part attributed to the lack of a standardised methodology for  
measuring waist and hip circumference (21).  However, these measures are useful to  
identify abdominal obesity, commonly defined as a waist-hip ratio of ≥0.90 for males  
and ≥0.85 for females, with waist measurement cut-offs varying according to sex and  
ethnicity (21).  However these measures cannot differentiate between visceral and  
subcutaneous adipose compartments (34). Visceral adiposity is positively related to  
cardiovascular disease, metabolic syndrome, type 2 diabetes, and several types of  
cancer (35-37), whereas subcutaneous adipose tissue has an anti-atherogenic effect  
(13). The associations of these different adipose tissue compartments are less well  
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characterised in assessment of cancer risk, at least partly because circumference 
measures and ratios used may be more variable between populations, and their 
interpretation is less studied and not well established. (38).  
 
Weight change.  The association of weight gain and loss with cancer risk has been 
evaluated in many studies and presents additional challenges.  
 
Weight gain throughout adulthood has been shown in the literature to increase risk of 
several cancers, such as postmenopausal breast cancer, endometrial, ovarian 
cancer, colon cancer, prostate cancer and kidney cancer (39, 40).  The Continuous 
Update Project has confirmed this link in endometrial, pancreatic and 
postmenopausal breast cancers (see Table 1). Weight gain may be a better marker 
of adiposity than BMI because it represents a snapshot of the weight trajectory 
throughout adult life, which in most adults results in accumulation of adipose tissue 
(39).  However, the assessment of weight gain in most studies has been based on 
recall, which may have led to measurement error, but generally expected to be 
random and resulting in attenuation of effect estimates (39).   
 
Intentional weight loss has been associated with reduced risk of cancer (41, 42), 
providing further support for a link between excess adiposity and disease risk.  This 
type of evidence has been challenged, however, (43) meaning that caution must be 
exercised when interpreting data on weight in isolation.  Furthermore, information on 
the intervention for weight loss is not always clearly reported, additionally clouding 
the findings.  Notably, intentionality of weight loss cannot always be included 
alongside measurements.  The possibility of “reverse causation”, resulting from 
undiagnosed pre-clinical disease or other chronic illness leading to weight loss, may 
produce spurious findings. One way to avoid this bias is to exclude subjects with 
serious illness and weight loss during the first few years of follow-up (44). However, 
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even after excluding these participants, the possibility of undiagnosed illness  
remains, particularly in certain populations such as smokers.  Bias due to reverse  
causation may also occur when illness or associated treatments cause weight gain  
(45). Overall, there is no clear solution in addressing the potential impact of reverse  
causation in studies exploring the relationship of BMI and cancer.  Nevertheless,  
bariatric surgery for weight loss has been associated with reduced risk of adiposity- 
related cancers (42), providing additional support for the obesity-cancer link.  
  
Measures of adiposity include skinfold thickness, which can be used to predict  
adipose tissue and its distribution; however the estimate is prone to measurement  
error and generally unfeasible to use in large population based studies.  Bioelectrical  
impedance analysis is another method used to measure adiposity that estimates lean  
and fat mass based on the principle that resistance to an electric current is greater in  
adipose tissue than in lean tissue. However, bioelectrical impedance measures yield  
similar estimates of disease risk to those derived from BMI alone (46).    
  
More direct and sophisticated measures of adiposity are available, such as air  
displacement plethysmography, underwater weighing (hydrodensitometry), dual- 
energy X-ray absorptiometry, ultrasound, computed tomography and magnetic  
resonance imaging (47). These methods show excellent reproducibility and validity  
(48, 49) and are increasingly being employed to measure adiposity at the tissue or  
organ levels, particularly in small-scale studies that require a high level of accuracy.  
However, due to high costs and lack of portability, their use in large-scale  
epidemiologic studies has been limited.  
  
Adult attained height represents a complex variable that depends on a combination  
of genetic, nutritional and other environmental factors. Greater height is associated  
with increased risk of many types of cancer, such as colorectal, ovarian and breast  
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cancer (1) (see Table 1). Hyperinsulinemia and enhanced levels of growth hormone 
and insulin-like growth factor 1, associated with maximal attained growth in pre-
adulthood, may partly contribute to this relationship (50). However, adult attained 
height does not characterise the growth trajectory, and may also be determined in 
part by other aspects of maturation, including genetic factors that may also be 
associated with increased cancer risk. 
 
Anthropometry throughout the life-course 
Pre-adult energy balance is an important, though not sole, determinant of adult 
height and physiologic indicators such as age at menarche (51, 52). Both 
epidemiologic and mechanistic studies conducted at the whole body, cellular and 
molecular levels suggest that accelerated growth in terms of weight, height or the 
timing of maturation of various hormonally mediated processes (adrenarche, 
menarche, puberty, pregnancy, lactation and menopause) can modulate site specific 
cancer risk (1).  
 
Birth weight, size and later growth (which can be assessed relative to established 
norms or standards) are predictors of risk for some types of cancer, such as 
colorectal, ovarian and breast cancer (1). An underlying susceptibility to cancer 
marked by excessive growth in utero and high birth weight (>4000g; macrosomia) 
(53), or impaired early growth marked by low birth weight (<2500g), may be revealed 
or activated by subsequent events later in life (54). These effects may in part be 
mediated by epigenetic control of gene expression, characterised by differential DNA 
methylation or acetylation of histones that define which specific genes are translated 
to bioactive proteins (55). Specific growth factors controlling adipose tissue growth 
and distribution may be affected, as well as hormonal responses including appetite 
control, thus defining subsequent obesity and disease risk, e.g. of diabetes (56). 
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Maternal obesity and gestational diabetes lead to excess fetal growth and excess  
adipose tissue at birth (57). Infants born with macrosomia are also at higher risk of  
obesity in later life, have earlier pubertal maturation and an increase in abdominal  
obesity, and increased risk of breast cancer (58). Recent evidence supports the  
notion of differential epigenetic changes in offspring of obese fathers and mothers,  
depending on which parent is obese, and on the timing of obesity (pre-conceptional  
or maternal at gestation) (59). These trans-generational consequences emphasise a  
need for life-course epidemiologic studies to unravel the causal relationships  
between early life events, including the timing of maturation and adiposity during  
growth and in adulthood, and the development and progression of cancer.  This is  
particularly necessary in view of the contrasting policy implications of the divergent  
effects of greater growth on cardiovascular disease and cancer risk (19).  
  
While there is growing evidence that risk of some cancers increases with greater  
adiposity (see Table 1) (1), the relevant critical periods throughout the life course are  
not fully understood. For example, the association between body weight and  
composition and breast cancer risk is complex.  Higher birth weight is associated with  
increased risk, and higher adiposity during adolescence and young adulthood with  
decreased risk of premenopausal cancer, but also with increased risk of  
postmenopausal cancer (58, 60) (although this pattern is not observed across all  
ethnicities (61)). This poses major challenges for epidemiologic studies, because  
complete understanding of these associations would require a longitudinal design  
with multiple measures of body weight and composition from birth to adulthood,  
which is generally not feasible. Another option is to rely on recall of self-reported  
body size at different time periods, which may lead to misclassification and bias.   
There are other markers of body size in adolescence such as Stunkard scales (62),  
which have revealed a link between body size and subsequent cancer risk (63, 64),  
and growth trajectories associated with elevated cancer risk (65).  It is clear that at  
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least for breast cancer, weight and body composition at critical periods (for example  
the prenatal period, at birth, in early childhood and in adolescence) is important to  
consider when evaluating contemporaneous body size. Further, it is suggested that  
obesity at critical stages of breast tissue evolution may compound oestrogenic effects  
(43).  For other cancers, these critical periods are not well known.  
  
Anthropometric measures, sex, and race/ethnic variation  
A final consideration in the relationship between the commonly used anthropometric  
markers of adiposity and cancer risk is that this relationship varies between sexes  
and among racial/ethnic groups (61, 66).  At the same BMI level, women tend to  
have higher body fat percentage compared with men (67).  BMI and other  
anthropometric variables have differential associations by sex with risks for some  
cancers including colon, gallbladder, renal, and pancreatic cancers (9).   
Several studies across the world have shown that body composition varies by  
race/ethnicity (21), and variations in the relationship between BMI and body fat  
percentage have been observed between Caucasian, African and Asian populations  
(68, 69). In addition, body composition and fat distribution appear to vary for different  
race/ethnic groups at similar BMIs (69-71). For example, Asian Indian men with a  
BMI of 24 kg/m2 and women with a BMI of 26 kg/m2 have the same percentage body  
fat as European adults with a BMI of 30 kg/m2, or Pacific men and women with BMI  
of 34 and 35 kg/m2 respectively (69). Additionally, race/ethnic variation in metabolic  
biomarkers is apparent after controlling for BMI (72).  For example, Asians have  
higher metabolic risk than Europeans at a given BMI, waist circumference or waist- 
to-hip ratio (69, 73).  This may contribute to observed ethnicity-related differences in  
cancer risk at similar levels of anthropometric measures of adiposity.   
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Thus, BMI represents different levels of adiposity and associated metabolic risk in  
different racial/ethnic groups. Specific cut-off points for comparison of obesity  
prevalence across ethnic groups have been proposed to reflect this (21). In a recent  
meta-analysis on adiposity and premenopausal breast cancer (61), ethnicity was the  
largest source of heterogeneity in the results. BMI was inversely related to  
premenopausal breast cancer among Caucasian and African women, while no  
association was observed among Asian women. When considering waist-to-hip ratio,  
the strongest risk was observed among Asian women (19% increased breast cancer  
risk per 0.1 unit increase) while the risk was lower among African and Caucasian  
women (5% and 6%, respectively) (61).  Variability in whole adipose tissue proportion  
and distribution according to ethnicity, and associated metabolic risks, need to be  
considered when conducting and interpreting results in epidemiologic studies.   
  
CONCLUSIONS  
In conclusion, obesity remains a major public health concern; of the various  
nutritional and dietary exposures evaluated in the WCRF/AICR Second Expert  
Report (1) and Continuous Update Project (2), anthropometric markers of adiposity  
have been found to be most strongly and consistently associated with the  
development and progression of several cancers. The current state of knowledge  
provides a strong basis for a public health recommendation to avoid excess adiposity  
in order to reduce cancer risk in adulthood.  
  
However, these findings arise from data and tools that are limited.  Many measures  
are interrelated, and it is often unclear how any individual marker relates to body  
composition, the growth trajectory, maturation, or the internal physiologic or  
metabolic milieu.  Specifically, it is essential to better characterise adiposity and the  
regional distribution of adipose tissue, as well as its site of deposition within or  
outside the abdominal cavity. It is also critical to understand how such aspects of  
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adiposity relate to other important markers of growth and maturation, and what the  
relevant susceptible periods throughout the life-course are for different cancers.  A  
clearer understanding of the biological pathways (physiological, metabolic, or at  
whole body or cellular levels) that underpin the links between body weight, size and  
composition through the life-course and risks of specific cancers will help to generate  
improved evidence on which to base public health policy and clinical management  
approaches for cancer prevention. This may be achieved through better integration of  
metabolic, clinical and laboratory studies with nutritional epidemiology.  With  
numbers of cancers predicted to increase throughout the world over the next  
decades, and obesity on the rise in many developing countries particularly, coherent  
preventive policies that address cancer prevention during the epidemiologic  
transitions are essential.  Although care is needed in their interpretation, existing  
anthropometric measures are useful tools for understanding the links between body  
size and composition and cancer. Future research on specific aspects of body  
composition that are linked to risk of cancer (and other chronic diseases) may help  
refine the use of anthropometry in this field.  
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Table 1. Cancer sites with strong evidence in the WCRF Continuous Update 
Project for an association between cancer risk and body fatness (adiposity), 
adult weight gain or adult attained height 
Cancer site Body 
mass 
index 
Waist 
circumference 
Waist-
hip 
ratio 
Adult 
weight 
gain 
Adult 
attained 
height 
Ref 
Stomach (cardia)1      (74) 
Kidney1      (75) 
Gallbladder1      (76) 
Liver1      (77) 
Prostate 
(advanced)1 
     (78) 
Ovarian1      (79) 
Endometrial1      (80) 
Pancreatic1      (81) 
Colorectal2      (82) 
Breast 
(postmenopausal)3 
     (83) 
Breast 
(premenopausal)1 
     (83) 
Oesophageal 
(adenocarcinoma)1 
     (1) 
 
 convincing increased risk;  probable increased risk;  probable decreased 
risk.  See supplementary information for definitions.  
1Judgement of ‘body fatness’  
2Judgement of ‘body fatness’ and ‘abdominal fatness’  
3Judgement of ‘body fatness’, ‘abdominal fatness’ and ‘adult weight gain’ 
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